Table 1.

Comparison of clinical behaviour scores for the general use of clinical guidelines at baseline and after the programmes

		Baseline		One year later		Two years later		Statisticsa
		Mean	s.d.	Mean	s.d.	Mean	s.d.	H	P-value
G1	Using treatment guidelines when deciding on the treatment policy in discussions with patients and family	34.0	±22.2	59.8b	±21.3	59.8c	±21.0	204.97	3.1 × 10−45
G2	Trying to treat patients in accordance with the guidelines if their previous treatments are not in accordance with guidelines	36.7	±21.8	61.6b	±20.0	58.5c	±21.1	192.27	1.8 × 10−42
G3	Pharmacotherapy for schizophrenia in your hospital/clinic is in accordance with the guideline	48.5	±22.4	59.9b	±21.7	62.2c	±21.4	62.40	2.8 × 10−14
G4	Recommending pharmacotherapy for schizophrenia to fellow doctors in accordance with the guideline	40.6	±24.5	61.9b	±23.2	64.3c	±21.4	138.20	9.8 × 10−31
G5	Treatment for depression in your hospital/clinic is in accordance with the guideline	48.7	±23.4	62.2b	±20.0	63.0c	±21.5	73.49	1.1 × 10−16
G6	Recommending treatment for depression to fellow doctors in accordance with the guideline	41.3	±24.3	62.2b	±23.5	65.3c	±20.8	138.38	8.9 × 10−31

The complete questions are noted in Supplementary Table 1. An intermediate value was used as the representative value for each of the five achievement levels: 0–20, 21–40, 41–60, 61–80 and 81–100. The scores ranged from 10 to 90.

^a.The Kruskal–Wallis test was used for the statistical analysis as the Kolmogorov–Smirnov test did not indicate normal distribution of clinical behaviour scores at baseline or 1 or 2 years after the programme. The significance level was set at <0.05.

^b.The mean scores of clinical behaviours increased significantly 1 year after attending the programme compared with baseline.

^c.The mean scores of clinical behaviours increased significantly 2 years after attending the programme compared with baseline.